Ctxr market cap
WebApr 10, 2024 · About CTXR Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products … WebMar 23, 2024 · (NASDAQ: CTXR) Citius Pharmaceuticals's market cap is $144.80M, as of Mar 23, 2024. Market cap (market capitalization) is the total market value of a publicly …
Ctxr market cap
Did you know?
Web(6 Analysts rating in the past 4-6wks since ALS & MS phase 2 data updates... all rated it a Buy & all with PT $7-15, representing MC b/n 500M-1B).. which is basically taking AMLX's 2B market cap and discounting back since AMLX has already gain approval after phase 2 trial extended life by a couple of months... under the unmet needs umbrella ... WebApr 13, 2024 · Citius Pharmaceuticals Inc. (NASDAQ:CTXR) shares, rose in value on Wednesday, 04/12/23, with the stock price up by 2.61% to the previous day’s close as strong demand from buyers drove the stock to $1.57. ... With the market capitalization of Citius Pharmaceuticals Inc. currently standing at about $219.56 million, investors are …
WebMar 2, 2024 · On Thursday, Citius Pharmaceuticals Inc (CTXR:NAQ) closed at 1.10, 42.86% above the 52 week low of 0.77 set on Dec 30, 2024. 52-week range Today 0.77 Dec 30 2024 2.01 Apr 06 2024 Markit short... WebCitius Pharmaceuticals Inc Working Capital Per Revenue on the trailing twelve month basis from the first quarter 2024 to first quarter 2024, Trends and Ranking, Fundamental Ratios - CSIMarket
WebMar 13, 2024 · CTXR has a market cap or net worth of $147.72 million as of March 14, 2024. Its market cap has decreased by -33.55% in one year. Market Cap. 147.72M. … WebApr 12, 2024 · Citius Pharmaceuticals' cash burn of US$29m is about 13% of its US$224m market capitalisation. As a result, we'd venture that the company could raise more cash for growth without much trouble, albeit at the cost of some dilution. Is Citius Pharmaceuticals' Cash Burn A Worry?
WebJul 1, 2024 · Citius Pharmaceuticals (CTXR) announces that the independent Data Monitoring Committee ((DMC)) for the Mino-LokPhase 3 Pivotal Superiority Trial has recommended to proceed with the trial...
WebApr 11, 2024 · Their CTXR share price forecasts range from $6.00 to $6.00. On average, they expect the company's stock price to reach $6.00 in the next year. This suggests a … streator national bank online bankingWebGet the latest Citius Pharmaceuticals Inc (CTXR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … rowlands pill pouchWebMar 31, 2024 · The main competitors of Citius Pharmaceuticals include Inventiva (IVA), F-star Therapeutics (FSTX), ADC Therapeutics (ADCT), Greenwich LifeSciences (GLSI), Alaunos Therapeutics (TCRT), Pyxis Oncology (PYXS), CorMedix (CRMD), PDS Biotechnology (PDSB), Nkarta (NKTX), and Cue Biopharma (CUE). These companies … rowlands pharmacy westvaleWebApr 6, 2024 · Here Are 2 Ways I'm Playing the Market With Small-Cap Stocks finance.yahoo.com - February 6 at 1:25 PM: Here's Why We're Not Too Worried About Citius Pharmaceuticals' (NASDAQ:CTXR) Cash Burn Situation finance.yahoo.com - January 16 at 11:49 AM: Citius Pharmaceuticals to Present at the Sidoti Micro-Cap … rowlands pharmacy westfaling street herefordWebJun 28, 2024 · Further, the global premium products market size for orphan and rare dermatology therapeutics is expected to be worth $6.07 billion by 2024. This presents a big market opportunity for Timber... rowlands pharmacy west park darlingtonWebCitius Pharmaceuticals, Inc., a late-stage pharmaceutical company, engages in the development and commercialization of critical care products focusing on oncology … rowlands pharmacy west lane keighleyWebAbout CTXR Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on … rowlands pharmacy wath